Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases

التفاصيل البيبلوغرافية
العنوان: Cytochrome b5 increases cytochrome P450 3A4-mediated activation of anticancer drug ellipticine to 13-hydroxyellipticine whose covalent binding to DNA is elevated by sulfotransferases and N,O-acetyltransferases
المؤلفون: Eva Frei, Marie Stiborová, Radek Indra, Václav Martínek, Věra Černá, Tomas Eckschlager, Michaela Moserová, Martina Rupertová, René Kizek
المصدر: Chemical research in toxicology. 25(5)
سنة النشر: 2012
مصطلحات موضوعية: Stereochemistry, Arylamine N-Acetyltransferase, Toxicology, chemistry.chemical_compound, Cytochrome b5, Animals, Cytochrome P-450 CYP3A, Humans, Prodrugs, Ellipticines, Heme, chemistry.chemical_classification, CYP3A4, biology, Chemistry, Cytochrome P450, Acetyltransferases, General Medicine, DNA, Prodrug, Antineoplastic Agents, Phytogenic, Enzyme, Cytochromes b5, Biochemistry, Covalent bond, biology.protein, Rabbits, Sulfotransferases
الوصف: The antineoplastic alkaloid ellipticine is a prodrug, whose pharmacological efficiency is dependent on its cytochrome P450 (P450)- and/or peroxidase-mediated activation in target tissues. The P450 3A4 enzyme oxidizes ellipticine to five metabolites, mainly to 13-hydroxy- and 12-hydroxyellipticine, the metabolites responsible for the formation of ellipticine-13-ylium and ellipticine-12-ylium ions that generate covalent DNA adducts. Cytochrome b(5) alters the ratio of ellipticine metabolites formed by P450 3A4. While the amounts of the detoxication metabolites (7-hydroxy- and 9-hydroxyellipticine) were not changed with added cytochrome b(5), 12-hydroxy- and 13-hydroxyellipticine, and ellipticine N(2)-oxide increased considerably. The P450 3A4-mediated oxidation of ellipticine was significantly changed only by holo-cytochrome b(5), while apo-cytochrome b(5) without heme or Mn-cytochrome b(5) had no such effect. The change in amounts of metabolites resulted in an increased formation of covalent ellipticine-DNA adducts, one of the DNA-damaging mechanisms of ellipticine antitumor action. The amounts of 13-hydroxy- and 12-hydroxyellipticine formed by P450 3A4 were similar, but more than 7-fold higher levels of the adduct were formed by 13-hydroxyellipticine than by 12-hydroxyellipticine. The higher susceptibility of 13-hydroxyellipticine toward heterolytic dissociation to ellipticine-13-ylium in comparison to dissociation of 12-hydroxyellipticine to ellipticine-12-ylium, determined by quantum chemical calculations, explains this phenomenon. The amounts of the 13-hydroxyellipticine-derived DNA adduct significantly increased upon reaction of 13-hydroxyellipticine with either 3'-phosphoadenosine-5'-phosphosulfate or acetyl-CoA catalyzed by human sulfotransferases 1A1, 1A2, 1A3, and 2A1, or N,O-acetyltransferases 1 and 2. The calculated reaction free energies of heterolysis of the sulfate and acetate esters are by 10-17 kcal/mol more favorable than the energy of hydrolysis of 13-hydroxyellipticine, which could explain the experimental data.
تدمد: 1520-5010
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950e0fee66fb42b65f30462e48b1d94f
https://pubmed.ncbi.nlm.nih.gov/22390216
رقم الانضمام: edsair.doi.dedup.....950e0fee66fb42b65f30462e48b1d94f
قاعدة البيانات: OpenAIRE